It looks like Fibrase is indicated for the treatment of IC, marketed by Janssen and made by bene-Pharmachem. It is essentially Elmiron for the Italian market, with the only difference being both the oral and injectable options available in Italy whereas Elmiron is only approved as a tablet by the FDA.
Dr Peter Ghosh helped file the patents for both Arthropharm and PAR, and was the co-founder (and part-owner) of both companies. This link is important as it means there would be no clash between the patents. One is clearly for animal use, the other for human use. Arthropharm also sources their PPS from bene-Pharmachem.
There appears to be one common denominator between Fibrase, Cartrophen and Zilosul - benePharmachem, which makes the exclusive supply agreement invaluable going forward.
(20min delay)